Security Snapshot

MYRIAD GENETICS INC - COMMON STOCK (MYGN) Institutional Ownership

CUSIP: 62855J104

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

200

Shares (Excl. Options)

87,875,411

Price

$4.50

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-3,560,583
Value change
-$21,788,135
Number of holders
200
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
94,128,234
SEC-reported price per share
$4.75
Insider filing price
$4.75
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • MYGN - MYRIAD GENETICS INC - COMMON STOCK is tracked under CUSIP 62855J104.
  • 200 institutions reported positions in Q1 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 220 to 200 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $567,141,060 to $395,512,395.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 200 institutions filings for Q1 2026.

Open SEC evidence

Security key

62855J104

Latest holder period

Q1 2026

13F holders

200

13D/G owners

7

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
MYGN
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.5% -45% $35,894,329 -$27,581,033 7,976,163 -43% BlackRock, Inc. 31 Mar 2026
INTEGRATED CORE STRATEGIES (US) LLC 7.2% +42% $41,205,972 +$12,003,761 6,700,158 +41% Millennium Management LLC 31 Dec 2025
GLENVIEW CAPITAL MANAGEMENT, LLC 5.3% $30,389,483 4,941,058 GLENVIEW CAPITAL MANAGEMENT, LLC 06 Jan 2026
STATE STREET CORP 4.7% -28% $21,102,609 -$7,357,916 4,424,027 -26% STATE STREET CORPORATION 31 Mar 2026
BARCLAYS PLC 4.2% -22% $28,480,691 -$6,945,955 3,939,238 -20% Barclays PLC 30 Sep 2025
Camber Capital Management LP 3.4% $22,320,000 3,100,000 Camber Capital Management LP 31 Dec 2024
DISCIPLINED GROWTH INVESTORS INC /MN 0.8% -86% $4,244,772 -$19,924,683 753,956 -82% DISCIPLINED GROWTH INVESTORS INC /MN 30 Jun 2025

As of 31 Mar 2026, 200 institutional investors reported holding 87,875,411 shares of MYRIAD GENETICS INC - COMMON STOCK (MYGN). This represents 93% of the company’s total 94,128,234 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
72%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9.4% 8,889,644 -42% 0% $40,003,403
MILLENNIUM MANAGEMENT LLC 7.1% 6,668,817 -0.47% 0.02% $30,009,676
GLENVIEW CAPITAL MANAGEMENT, LLC 5.7% 5,411,978 +18% 0.66% $24,353,901
D. E. Shaw & Co., Inc. 4.8% 4,499,724 -0.12% 0.02% $20,248,758
STATE STREET CORP 4.7% 4,424,027 -26% 0% $19,908,122
VANGUARD CAPITAL MANAGEMENT LLC 4.2% 3,924,525 0% 0% $17,660,363
MORGAN STANLEY 3.4% 3,168,742 -12% 0% $14,259,341
VANGUARD PORTFOLIO MANAGEMENT LLC 2.7% 2,582,231 0% 0% $11,620,040
GOLDMAN SACHS GROUP INC 2.5% 2,366,092 +9.5% 0% $10,647,414
GEODE CAPITAL MANAGEMENT, LLC 2.5% 2,319,379 +3.9% 0% $10,439,417
ACADIAN ASSET MANAGEMENT LLC 2.5% 2,308,589 +134% 0.01% $10,378,000
JACOBS LEVY EQUITY MANAGEMENT, INC 2.2% 2,088,492 -8% 0.04% $9,398,214
FEDERATED HERMES, INC. 2.1% 1,976,166 +51% 0.01% $8,892,747
AQR CAPITAL MANAGEMENT LLC 2% 1,912,296 +2.2% 0% $8,605,334
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.9% 1,801,478 +2.7% 0% $8,106,651
HRT FINANCIAL LP 1.9% 1,786,319 +281% 0.02% $8,038,000
Qube Research & Technologies Ltd 1.8% 1,690,461 +94% 0.01% $7,607,075
Vestal Point Capital, LP 1.8% 1,648,000 +35% 0.21% $7,416,000
Assenagon Asset Management S.A. 1.5% 1,446,961 +24% 0.01% $6,511,325
Connor, Clark & Lunn Investment Management Ltd. 1.4% 1,318,663 +14% 0.01% $5,933,984
TWO SIGMA INVESTMENTS, LP 1.4% 1,284,050 +40% 0% $5,778,225
JANE STREET GROUP, LLC 1.3% 1,202,531 +2110% 0.01% $5,411,389
Fisher Asset Management, LLC 1.3% 1,190,896 -1.3% 0% $5,359,031
Aberdeen Group plc 1.2% 1,110,404 +25% 0.01% $4,996,818
MARSHALL WACE, LLP 1.2% 1,103,758 +4849% 0.01% $4,966,914

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 87,875,411 $395,512,395 -$21,788,135 $4.50 200
2025 Q4 92,194,007 $567,141,060 +$27,455,645 $6.15 220
2025 Q3 88,492,355 $639,685,484 +$7,333,020 $7.23 215
2025 Q2 90,529,530 $480,755,771 -$73,903,588 $5.31 216
2025 Q1 93,969,029 $833,362,943 +$10,158,296 $8.87 226
2024 Q4 92,375,178 $1,266,992,283 -$38,609,730 $13.71 215
2024 Q3 90,691,605 $2,483,201,789 -$46,730,979 $27.39 242
2024 Q2 92,267,243 $2,256,709,187 -$39,028,941 $24.46 222
2024 Q1 93,842,572 $2,001,184,496 +$85,643,654 $21.32 185
2023 Q4 89,898,458 $1,720,778,542 +$139,092,939 $19.14 193
2023 Q3 82,696,930 $1,326,499,466 +$18,782,858 $16.04 184
2023 Q2 81,069,882 $1,879,159,822 -$25,379,016 $23.18 184
2023 Q1 82,216,167 $1,909,846,418 +$45,174,636 $23.23 186
2022 Q4 80,553,035 $1,168,812,560 -$19,067,888 $14.51 191
2022 Q3 81,539,353 $1,555,961,809 +$26,155,420 $19.08 184
2022 Q2 79,888,231 $1,451,741,809 +$19,085,207 $18.17 185
2022 Q1 78,868,034 $1,987,215,536 +$13,382,979 $25.20 198
2021 Q4 78,283,503 $2,159,672,726 -$41,784,396 $27.60 191
2021 Q3 79,271,409 $2,560,639,030 +$122,124,573 $32.29 208
2021 Q2 75,479,842 $2,308,615,173 +$49,345,949 $30.58 198
2021 Q1 73,860,328 $2,248,603,947 -$35,142,715 $30.45 193
2020 Q4 74,996,999 $1,483,013,849 +$38,048,718 $19.78 176
2020 Q3 78,424,909 $1,022,586,628 +$19,999,510 $13.04 185
2020 Q2 72,886,989 $826,507,154 -$36,910,370 $11.34 188
2020 Q1 73,615,521 $1,053,548,995 -$123,804,400 $14.31 182
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .